Zhitong Finance App News, Shengnuo Pharmaceutical-B (02257) issued an announcement. On July 21, 2026, the company established an external scientific advisory committee (scientific advisory committee) to provide independent and authoritative scientific guidance for the Group's treatment pipeline research and development projects. The Scientific Advisory Board consists of five internationally renowned interdisciplinary experts with deep expertise in RNA delivery technology, RNAi drug discovery, oncology research and development (R&D), clinical translational medicine, chemistry, manufacturing and control (CMC) activities, and global drug regulatory compliance.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.